Table V.
Component | Standardization method | Example | Standardized name |
---|---|---|---|
MHC molecule | MHC Restriction Ontology (MRO) | A0201 | HLA-A*02:01 |
Peptidic ligand | Nomenclature Committee of the International Union of Biochemistry (IUPAC-IUB) | SLYNTVATL | SLYNTVATL |
Non-peptidic ligand | Chemical Entities of Biological Interest (ChEBI) | α-GalCer | 1-O-(α-D-galactosyl)-N-hexacosanoylphytosphingosine |
Post translational modification | Protein Modification Ontology (PSI-MOD) | Acetylation | acetylated residue |
Modification position | Letter followed by position in ligand | the first leucine in SLYNTVATL | L2 |